These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 25496327)
1. Uncovering the cathepsin system in heart failure patients submitted to Left Ventricular Assist Device (LVAD) implantation. D'Amico A; Ragusa R; Caruso R; Prescimone T; Nonini S; Cabiati M; Del Ry S; Trivella MG; Giannessi D; Caselli C J Transl Med; 2014 Dec; 12():350. PubMed ID: 25496327 [TBL] [Abstract][Full Text] [Related]
2. Cardiac molecular markers of programmed cell death are activated in end-stage heart failure patients supported by left ventricular assist device. Prescimone T; Masotti S; D'Amico A; Caruso R; Cabiati M; Caselli C; Viglione F; Verde A; Del Ry S; Giannessi D Cardiovasc Pathol; 2014; 23(5):272-82. PubMed ID: 24856512 [TBL] [Abstract][Full Text] [Related]
3. Short-term mechanical unloading and reverse remodeling of failing hearts in children. Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184 [TBL] [Abstract][Full Text] [Related]
4. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device. Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217 [TBL] [Abstract][Full Text] [Related]
5. IL-33/ST2 pathway and classical cytokines in end-stage heart failure patients submitted to left ventricular assist device support: a paradoxic role for inflammatory mediators? Caselli C; D'Amico A; Ragusa R; Caruso R; Prescimone T; Cabiati M; Nonini S; Marraccini P; Del Ry S; Trivella MG; Parodi O; Giannessi D Mediators Inflamm; 2013; 2013():498703. PubMed ID: 24385685 [TBL] [Abstract][Full Text] [Related]
6. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support. Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579 [TBL] [Abstract][Full Text] [Related]
7. Exercise performance of chronic heart failure patients in the early period of support by an axial-flow left ventricular assist device as destination therapy. Compostella L; Russo N; Setzu T; Compostella C; Bellotto F Artif Organs; 2014 May; 38(5):366-73. PubMed ID: 24117945 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of CaMKII Attenuates Progressing Disruption of Ca(2+) Homeostasis Upon Left Ventricular Assist Device Implantation in Human Heart Failure. Fischer TH; Kleinwächter A; Herting J; Eiringhaus J; Hartmann N; Renner A; Gummert J; Haverich A; Schmitto JD; Sossalla S Artif Organs; 2016 Aug; 40(8):719-26. PubMed ID: 26816346 [TBL] [Abstract][Full Text] [Related]
9. Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant. Yuzefpolskaya M; Bohn B; Nasiri M; Zuver AM; Onat DD; Royzman EA; Nwokocha J; Mabasa M; Pinsino A; Brunjes D; Gaudig A; Clemons A; Trinh P; Stump S; Giddins MJ; Topkara VK; Garan AR; Takeda K; Takayama H; Naka Y; Farr MA; Nandakumar R; Uhlemann AC; Colombo PC; Demmer RT J Heart Lung Transplant; 2020 Sep; 39(9):880-890. PubMed ID: 32139154 [TBL] [Abstract][Full Text] [Related]
10. Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure. Lee SH; Doliba N; Osbakken M; Oz M; Mancini D J Thorac Cardiovasc Surg; 1998 Aug; 116(2):344-9. PubMed ID: 9699589 [TBL] [Abstract][Full Text] [Related]
11. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659 [TBL] [Abstract][Full Text] [Related]
12. Caspase-1 transcripts in failing human heart after mechanical unloading. Prescimone T; D'Amico A; Caselli C; Cabiati M; Viglione F; Caruso R; Verde A; Del Ry S; Trivella MG; Giannessi D Cardiovasc Pathol; 2015; 24(1):11-8. PubMed ID: 25200478 [TBL] [Abstract][Full Text] [Related]
13. Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support. Lok SI; Nous FM; van Kuik J; van der Weide P; Winkens B; Kemperman H; Huisman A; Lahpor JR; de Weger RA; de Jonge N Eur J Cardiothorac Surg; 2015 Sep; 48(3):407-15. PubMed ID: 25609773 [TBL] [Abstract][Full Text] [Related]
14. Chronotropic incompetence and abnormal heart rate recovery early after left ventricular assist device implantation. Dimopoulos S; Diakos N; Tseliou E; Tasoulis A; Mpouchla A; Manetos C; Katsaros L; Drakos S; Terrovitis J; Nanas S Pacing Clin Electrophysiol; 2011 Dec; 34(12):1607-14. PubMed ID: 21950763 [TBL] [Abstract][Full Text] [Related]